PER 1.23% 8.0¢ percheron therapeutics limited

atl1102 a clear winner, page-4

  1. 13,117 Posts.
    lightbulb Created with Sketch. 1370
    Stunning yes.....Revenue for 2016 a staggering $8.5 BILLION.for stem cell growth products...
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.